lapatinib has been researched along with epothilone b in 2 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (epothilone b) | Trials (epothilone b) | Recent Studies (post-2010) (epothilone b) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 305 | 27 | 129 |
| Protein | Taxonomy | lapatinib (IC50) | epothilone b (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egerton, N | 1 |
| Li, F; Ma, L; Niu, Y; Yan, C; Zhao, W | 1 |
1 review(s) available for lapatinib and epothilone b
| Article | Year |
|---|---|
Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Marrow; Breast Neoplasms; Capecitabine; Clinical Trials, Phase II as Topic; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Interactions; Epothilones; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Lymphatic Metastasis; Peripheral Nervous System Diseases; Quinazolines; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2010 |
1 other study(ies) available for lapatinib and epothilone b
| Article | Year |
|---|---|
System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Biomarkers, Tumor; DNA-Binding Proteins; Epothilones; Gene Expression Regulation, Neoplastic; Humans; Interleukin-18; Lapatinib; Pancreatic Neoplasms; Pore Forming Cytotoxic Proteins; Prognosis; Pyroptosis | 2022 |